PL358688A1 - Estry kwasu karbamowego jako inhibitory czynnika XA - Google Patents
Estry kwasu karbamowego jako inhibitory czynnika XAInfo
- Publication number
- PL358688A1 PL358688A1 PL01358688A PL35868801A PL358688A1 PL 358688 A1 PL358688 A1 PL 358688A1 PL 01358688 A PL01358688 A PL 01358688A PL 35868801 A PL35868801 A PL 35868801A PL 358688 A1 PL358688 A1 PL 358688A1
- Authority
- PL
- Poland
- Prior art keywords
- inhibitors
- factor
- acid esters
- carbamic acid
- carbamic
- Prior art date
Links
- 108010074860 Factor Xa Proteins 0.000 title 1
- 229940112021 centrally acting muscle relaxants carbamic acid ester Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Confectionery (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10027024A DE10027024A1 (de) | 2000-05-31 | 2000-05-31 | Carbaminsäureester |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL358688A1 true PL358688A1 (pl) | 2004-08-09 |
Family
ID=7644254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01358688A PL358688A1 (pl) | 2000-05-31 | 2001-04-10 | Estry kwasu karbamowego jako inhibitory czynnika XA |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20030199698A1 (pl) |
| EP (1) | EP1289941A1 (pl) |
| JP (1) | JP2003535074A (pl) |
| KR (1) | KR20030007752A (pl) |
| AR (1) | AR029931A1 (pl) |
| AU (1) | AU2001260193A1 (pl) |
| BR (1) | BR0111059A (pl) |
| CA (1) | CA2410628A1 (pl) |
| CZ (1) | CZ20023588A3 (pl) |
| DE (1) | DE10027024A1 (pl) |
| HU (1) | HUP0301957A2 (pl) |
| MX (1) | MXPA02011801A (pl) |
| NO (1) | NO20025740L (pl) |
| PL (1) | PL358688A1 (pl) |
| SK (1) | SK15522002A3 (pl) |
| WO (1) | WO2001092214A1 (pl) |
| ZA (1) | ZA200210301B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200410921A (en) * | 2002-11-25 | 2004-07-01 | Hoffmann La Roche | Mandelic acid derivatives |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19530996A1 (de) * | 1995-08-23 | 1997-02-27 | Boehringer Mannheim Gmbh | Cyclische Guanidine, Verfahren zu ihrer Herstellung und Arzneimittel |
| DE19755268A1 (de) * | 1997-12-12 | 1999-06-17 | Merck Patent Gmbh | Benzamidinderivate |
| DE19819548A1 (de) * | 1998-04-30 | 1999-11-04 | Merck Patent Gmbh | Biphenylderivate |
-
2000
- 2000-05-31 DE DE10027024A patent/DE10027024A1/de active Pending
-
2001
- 2001-04-10 MX MXPA02011801A patent/MXPA02011801A/es unknown
- 2001-04-10 CZ CZ20023588A patent/CZ20023588A3/cs unknown
- 2001-04-10 HU HU0301957A patent/HUP0301957A2/hu unknown
- 2001-04-10 JP JP2002500829A patent/JP2003535074A/ja active Pending
- 2001-04-10 CA CA002410628A patent/CA2410628A1/en not_active Abandoned
- 2001-04-10 SK SK1552-2002A patent/SK15522002A3/sk unknown
- 2001-04-10 EP EP01933812A patent/EP1289941A1/de not_active Withdrawn
- 2001-04-10 PL PL01358688A patent/PL358688A1/pl unknown
- 2001-04-10 WO PCT/EP2001/004112 patent/WO2001092214A1/de not_active Ceased
- 2001-04-10 BR BR0111059-4A patent/BR0111059A/pt not_active Application Discontinuation
- 2001-04-10 AU AU2001260193A patent/AU2001260193A1/en not_active Abandoned
- 2001-04-10 US US10/296,761 patent/US20030199698A1/en not_active Abandoned
- 2001-04-10 KR KR1020027016190A patent/KR20030007752A/ko not_active Withdrawn
- 2001-05-30 AR ARP010102578A patent/AR029931A1/es unknown
-
2002
- 2002-11-29 NO NO20025740A patent/NO20025740L/no not_active Application Discontinuation
- 2002-12-19 ZA ZA200210301A patent/ZA200210301B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200210301B (en) | 2004-09-06 |
| NO20025740D0 (no) | 2002-11-29 |
| US20030199698A1 (en) | 2003-10-23 |
| WO2001092214A1 (de) | 2001-12-06 |
| KR20030007752A (ko) | 2003-01-23 |
| DE10027024A1 (de) | 2001-12-06 |
| HUP0301957A2 (hu) | 2003-11-28 |
| AU2001260193A1 (en) | 2001-12-11 |
| CZ20023588A3 (cs) | 2003-02-12 |
| JP2003535074A (ja) | 2003-11-25 |
| MXPA02011801A (es) | 2003-04-10 |
| EP1289941A1 (de) | 2003-03-12 |
| BR0111059A (pt) | 2003-04-15 |
| NO20025740L (no) | 2002-11-29 |
| CA2410628A1 (en) | 2002-11-28 |
| AR029931A1 (es) | 2003-07-23 |
| SK15522002A3 (sk) | 2003-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT1366018T (lt) | (r)-2-arilpropiono rūgščių omega-amino alkilamidai kaip polimorfonuklearinių ir mononuklearinių ląstelių chemotaksio inhibitoriai | |
| IL148698A0 (en) | INHIBITORS OF FACTOR Xa | |
| EP1487776A4 (en) | ACID COMPOUNDS AND ESTERS AND METHODS OF USE THEREOF | |
| AU2001297648A1 (en) | Substituted carboxamides as inhibitors of factor xa | |
| ITMI20000559A0 (it) | Esteri polisaccaridici di n-derivati di acido glutammico | |
| IL145772A0 (en) | Prodrugs of thrombin inhibitors | |
| PL358688A1 (pl) | Estry kwasu karbamowego jako inhibitory czynnika XA | |
| GB2375762B (en) | Stereospecific synthesis of 2-hydroxy-4-phenyl-butyric acid esters | |
| IL149364A0 (en) | Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 | |
| AU7608100A (en) | 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors | |
| GB0230240D0 (en) | Removal of an acid | |
| IL164773A0 (en) | Ester derivatives of a decahydroisoquinoline-3-carboxlic acid as analgesics | |
| IL165125A0 (en) | Use of new etonogestrel esters | |
| AU2001289723A1 (en) | Novel use of difluoromalonic acid esters | |
| PL1611083T3 (pl) | Synteza estrów kwasu 2-chlorometylo-6-metylobenzoesowego | |
| HUP0202431A3 (en) | Prodrugs of thrombin inhibitors | |
| GB0214711D0 (en) | Novel phosphonocarboxylic acid esters | |
| EE04960B1 (et) | Meetod arliminometlkarbamiinhappeestrite valmistamiseks | |
| SI1611083T1 (sl) | Sinteza estrov 2-klorometil-6-metil-benzojske kisline | |
| IL166778A0 (en) | Derivatives of gl ycinergic r(+)-2-amino-3-hydroxypropanoic acid | |
| AU2002302885A1 (en) | Stereoselective synthesis of 2-hydroxy-4-phenylbutyric acid esters | |
| GB0116292D0 (en) | Novel phosphonocarboxylic acid esters | |
| AU2002247145A1 (en) | Sophthalic acid glycol ester solution | |
| HU2029U (en) | Equipment for continuously esterification of sebacic acid | |
| GB0019819D0 (en) | Novel phosphonocarboxylic acid esters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |